$1.38
-0.025[-1.78%]
At close: Apr 23
$1.38
0[0.00%]
PreMarket: 2:20AM EDT
Spero Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Spero Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | SPRO | Q1 | -$0.25 | -$0.12 | — | — | $2.07M | $16.93M | — | — | Get Alert |
03/13/2024 | PM | SPRO | Q4 | $0.55 | -$0.10 | $0.96 | 1060.00% | $47.44M | $18.63M | $73.52M | 294.65% | Get Alert |
11/13/2023 | PM | SPRO | Q3 | -$0.33 | -$0.03 | -$0.06 | -100.00% | $2.01M | $14.97M | $25.47M | 70.16% | Get Alert |
08/10/2023 | PM | SPRO | Q2 | -$0.51 | -$0.34 | -$0.23 | 32.35% | $1.99M | $1.07M | $2.72M | 153.83% | Get Alert |
05/11/2023 | PM | SPRO | Q1 | -$1.01 | -$0.33 | -$0.25 | 24.24% | $2.07M | $1.00M | $2.07M | 106.90% | Get Alert |
03/30/2023 | PM | SPRO | Q4 | -$0.90 | $0.04 | $0.55 | 1275.00% | $2.74M | $22.87M | $47.44M | 107.44% | Get Alert |
11/14/2022 | PM | SPRO | Q3 | -$0.70 | -$0.30 | -$0.33 | -10.00% | $3.06M | $5.42M | $2.01M | -62.99% | Get Alert |
08/10/2022 | PM | SPRO | Q2 | -$0.63 | -$0.54 | -$0.51 | 5.56% | $5.15M | $1.15M | $1.99M | 73.30% | Get Alert |
05/16/2022 | PM | SPRO | Q1 | -$0.66 | -$0.87 | -$1.01 | -16.09% | $7.30M | $2.57M | $2.07M | -19.49% | Get Alert |
03/31/2022 | PM | SPRO | Q4 | -$0.68 | -$0.75 | -$0.90 | -20.00% | $1.91M | $4.95M | $2.74M | -44.57% | Get Alert |
11/10/2021 | PM | SPRO | Q3 | -$0.86 | -$0.66 | -$0.70 | -6.06% | $4.00M | $4.47M | $3.06M | -31.45% | Get Alert |
08/05/2021 | PM | SPRO | Q2 | -$0.85 | -$0.77 | -$0.63 | 18.18% | $1.73M | $4.03M | $5.15M | 27.74% | Get Alert |
05/06/2021 | PM | SPRO | Q1 | -$1.22 | -$0.64 | -$0.66 | -3.12% | $1.70M | $3.16M | $7.30M | 131.01% | Get Alert |
03/11/2021 | PM | SPRO | Q4 | -$1.32 | -$0.74 | -$0.68 | 8.11% | $3.63M | $3.67M | $1.91M | -48.04% | Get Alert |
11/05/2020 | PM | SPRO | Q3 | -$0.95 | -$0.87 | -$0.86 | 1.15% | $4.64M | $3.20M | $4.00M | 24.84% | Get Alert |
08/06/2020 | PM | SPRO | Q2 | -$0.74 | -$1.12 | -$0.85 | 24.11% | $2.16M | $3.40M | $1.73M | -49.21% | Get Alert |
05/08/2020 | AM | SPRO | Q1 | -$0.29 | -$1.25 | -$1.22 | 2.40% | $7.72M | $3.44M | $1.70M | -50.55% | Get Alert |
03/16/2020 | PM | SPRO | Q4 | -$0.60 | — | -$1.32 | — | $1.69M | — | $3.63M | — | Get Alert |
11/04/2019 | PM | SPRO | Q3 | -$0.60 | -$0.85 | -$0.95 | -11.76% | $658.00K | $2.45M | $4.64M | 89.51% | Get Alert |
Spero Therapeutics (SPRO) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 13, 2024 for Q4.
The Actual EPS was $0.96, which beat the estimate of $-0.10.
The Actual Revenue was $73.5M, which beat the estimate of $18.6M.
Browse earnings estimates, EPS, and revenue on all stocks.